Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-26,450
Closed -$993K 705
2022
Q4
$993K Sell
26,450
-13,539
-34% -$537K 0.16% 222
2022
Q3
$1.5M Sell
39,989
-54,019
-57% -$2.14M 0.23% 118
2022
Q2
$3.39M Buy
+94,008
New +$3.89M 0.3% 65
2015
Q4
Sell
-70,779
Closed -$2.1M 883
2015
Q3
$2.1M Buy
+70,779
New +$2.17M 0.05% 423
2015
Q2
Sell
-69,393
Closed -$1.94M 1615
2015
Q1
$1.94M Buy
69,393
+31,517
+83% +$855K 0.05% 465
2014
Q4
$1.03M Sell
37,876
-66,424
-64% -$1.68M 0.1% 254
2014
Q3
$2.47M Sell
104,300
-17,147
-14% -$411K 0.06% 355
2014
Q2
$2.96M Buy
+121,447
New +$2.83M 0.08% 316

Other funds holding SNV

PDT Partners's SNV Position: Q1 2023 in Review

PDT Partners sold out of Synovus (SNV) in Q1 2023, closing a stake of 26,450 shares — an estimated $993K sold.

PDT Partners first reported a position in SNV in Q2 2014 and held it in 8 quarters. The position peaked at $3.39M in Q2 2022. 377 funds tracked by Wall St. Rank hold SNV as of Q1 2023.

  • PDT Partners reported no remaining Synovus position as of Q1 2023 after selling out during the quarter.
  • PDT Partners sold 26,450 Synovus shares in Q1 2023, an estimated $993K.
  • PDT Partners first reported a position in Synovus in Q2 2014 and held it in 8 quarters.
  • PDT Partners's Synovus position peaked at $3.39M in Q2 2022.
  • 377 funds tracked by Wall St. Rank held Synovus as of Q1 2023.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.